Salle de presse
juin 24, 2021
Bioventus Invests in Vaporox
Ultrasonic Technology to Heal Diabetic Foot Ulcers DURHAM, NC – June 24, 2021 – Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global…
juin 16, 2021
Bioventus to Release Second Quarter of Fiscal Year 2021 Financial Results on August 10, 2021
DURHAM, NC – June 16, 2021 – Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today…
mai 25, 2021
Bioventus Study Shows Novel Placental Tissue Biologic Candidate Inhibited Inflammatory and Catabolic Responses In Vitro
Demonstrated Significant Reduction of Pain and Cartilage Degeneration in Rat Osteoarthritis Model DURHAM, NC – May 25, 2021 – Bioventus Inc. (Nasdaq:…
mai 17, 2021
Bioventus Senior Management to Present at Upcoming Investor Conferences
DURHAM, NC – May 17, 2021 – Senior management of Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for…
mai 12, 2021
Bioventus Inc. Reports First Quarter Results; Updates Full Year 2021 Financial Guidance
DURHAM, NC – May 12, 2021 – Bioventus Inc. (Nasdaq: BVS) ("Bioventus" or "the Company"), a global leader in innovations for active healing, today…
avril 27, 2021
Bioventus Announces First Commercial Shipment of the Bioness® Integrated Therapy System (BITS) Balance System
Fourteen Facilities Across the US Receive Multidisciplinary Therapy Solution VALENCIA, CA – April 27, 2021 – Bioventus Inc. (Nasdaq: BVS)…
avril 12, 2021
Bioventus to Release First Quarter of Fiscal Year 2021 Financial Results on May 12, 2021
DURHAM, NC - April 12, 2021 - Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today…
mars 30, 2021
Bioventus Acquires Bioness, Inc.
DURHAM, NC – March 30, 2021 – Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has…
mars 25, 2021
Bioventus Inc. Reports Fourth Quarter and Full Year 2020 Financial Results; Introduces Full Year 2021 Financial Guidance
DURHAM, NC – March 25, 2021 – Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today…
mars 11, 2021
Bioventus Reports First Patients Enrolled in Phase 1 Clinical Trial of MOTYS(TM) (PTP-001) for the Treatment of Knee OA
DURHAM, NC – March 11, 2021 – Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a leader in solutions for innovative healing, reported…
Recherche sur les nouvelles
Requêtes médiatiques
Thomas Hill
Directeur des communications de l’entreprise
919.474.6715
[email protected]
Bibliothèque de téléchargement
Logos de l’entreprise et de la marque
Télécharger maintenant
Images du produit
Télécharger maintenant
